Product information

Current status:

Cancelled Pre Market

Current status date:

2021-02-01

Original market date: ^{See footnote 1}

Product name:

OXAZEPAM 30MG TABLETS

DIN:

02232732 Electronic product monograph is not available

Company:

LABORATOIRES CONFAB INC
4355 Boul. Sir Wilfrid Laurier
St-Hubert
Quebec
Canada J3Y 3X3

Class:

Human

Dosage form(s):

Tablet

Route(s) of administration:

Oral

Number of active ingredient(s):

1

Schedule(s):

TARGETED SUBSTANCES (CDSA IV)

American Hospital Formulary Service (AHFS): ^{See footnote 3}

28:24.08 

Anatomical Therapeutic Chemical (ATC): ^{See footnote 4}

N05BA04 OXAZEPAM

Active ingredient group (AIG) number:^{See footnote5}

0102420001